Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Sarepta Therapeutics buy melinda

Start price
€131.66
02.11.18 / 50%
Target price
€144.32
04.11.21
Performance (%)
-52.21%
End price
€62.92
26.03.21
Summary
This prediction ended on 26.03.21 with a price of €62.92. Massive losses of -52.21% were the result for the BUY prediction by melinda. melinda has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Sarepta Therapeutics -1.409% -1.409% 10.865% 112.071%
iShares Core DAX® 4.094% 3.543% 17.404% 20.326%
iShares Nasdaq 100 1.424% 0.512% 39.212% 55.365%
iShares Nikkei 225® -1.572% -4.633% 15.731% 2.146%
iShares S&P 500 1.822% 0.963% 30.396% 45.950%

According to melinda what are the pros and cons of Sarepta Therapeutics for the foreseeable future?

Pros
Could be worthwhile Investment >10% per year
Cons

Comments by melinda for this prediction

In the thread Sarepta Therapeutics diskutieren
Prediction Buy
Perf. (%) -52.21%
Target price 144.320
Change
Ends at 04.11.21

SecteurRecherche biotechnologique et médicale Agenda 28/02 Publication de résultats



Métier
Logo Sarepta Therapeutics Inc
Researches and develops treatments for life-threatening illnesses and viruses

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare neuromuscular diseases.

It focuses on the development of its potentially disease-modifying Duchenne Muscular Dystrophy drug candidates.

The company was founded on July 22, 1980 and is headquartered in Cambridge, MA.

Nombre d'employés : 255 personnes.



In the thread Trading Sarepta Therapeutics
Prediction Buy
Perf. (%) -52.21%
Target price 144.320
Change
Ends at 04.11.21

Buy beendet

Stopped prediction by melinda for Sarepta Therapeutics

buy
Sarepta Therapeutics

Start price
Target price
Perf. (%)
€119.00
15.10.18
€135.30
02.11.18
10.17%
02.11.18

Could be worthwhile Investment >10% per year
buy
Sarepta Therapeutics

Start price
Target price
Perf. (%)
€91.74
16.06.18
€94.71
19.06.18
57.31%
19.06.18

Could be worthwhile Investment >10% per year
buy
Sarepta Therapeutics

Start price
Target price
Perf. (%)
€56.52
02.03.18
€84.79
08.03.18
17.79%
08.03.18

Could be worthwhile Investment >10% per year
buy
Sarepta Therapeutics

Start price
Target price
Perf. (%)
€51.03
08.10.17
€55.00
29.12.17
11.09%
29.12.17

Could be worthwhile Investment >10% per year
buy
Sarepta Therapeutics

Start price
Target price
Perf. (%)
€46.03
08.10.17
€49.61
29.12.17
11.09%
29.12.17

Could be worthwhile Investment >10% per year
buy
Sarepta Therapeutics

Start price
Target price
Perf. (%)
€41.00
20.07.17
€45.00
21.07.17
1.24%
21.07.17

Could be worthwhile Investment >10% per year
buy
Sarepta Therapeutics

Start price
Target price
Perf. (%)
€36.98
20.07.17
€40.59
21.07.17
1.24%
21.07.17

Could be worthwhile Investment >10% per year
buy
Sarepta Therapeutics

Start price
Target price
Perf. (%)
€32.56
11.01.17
€88.40
28.04.17
2.91%
28.04.17

Could be worthwhile Investment >10% per year
buy
Sarepta Therapeutics

Start price
Target price
Perf. (%)
€23.54
23.08.16
€24.81
24.08.16
5.36%
24.08.16

Could be worthwhile Investment >10% per year
buy
Sarepta Therapeutics

Start price
Target price
Perf. (%)
€18.50
09.06.16
€19.84
08.07.16
8.82%
08.07.16

Could be worthwhile Investment >10% per year
buy
Sarepta Therapeutics

Start price
Target price
Perf. (%)
€16.64
03.05.16
€18.04
23.05.16
8.57%
23.05.16

Could be worthwhile Investment >10% per year
buy
Sarepta Therapeutics

Start price
Target price
Perf. (%)
€7.49
23.04.16
€16.24
03.05.16
120.49%
03.05.16

Could be worthwhile Investment >10% per year
buy
Sarepta Therapeutics

Start price
Target price
Perf. (%)
€14.88
14.03.16
€18.04
21.03.16
22.62%
21.03.16

Could be worthwhile Investment >10% per year
buy
Sarepta Therapeutics

Start price
Target price
Perf. (%)
€39.53
04.10.13
€41.00
04.04.14
-55.30%
04.04.14

Could be worthwhile Investment >10% per year